Blue Sky Capital Consultants Group, Inc. Moderna, Inc. Transaction History
Blue Sky Capital Consultants Group, Inc.
- $166 Billion
- Q4 2024
A detailed history of Blue Sky Capital Consultants Group, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Blue Sky Capital Consultants Group, Inc. holds 14,563 shares of MRNA stock, worth $517,423. This represents 0.36% of its overall portfolio holdings.
Number of Shares
14,563Holding current value
$517,423% of portfolio
0.36%Shares
1 transactions
Others Institutions Holding MRNA
# of Institutions
922Shares Held
255MCall Options Held
19MPut Options Held
24.3M-
Vanguard Group Inc Valley Forge, PA40.3MShares$1.43 Billion0.03% of portfolio
-
Baillie Gifford & CO38.9MShares$1.38 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$908 Million0.07% of portfolio
-
State Street Corp Boston, MA17.6MShares$625 Million0.03% of portfolio
-
Theleme Partners LLP London, X07.31MShares$260 Million20.37% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $13.9B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...